Edition:
United Kingdom

Nichi-Iko Pharmaceutical Co Ltd (4541.T)

4541.T on Tokyo Stock Exchange

1,705JPY
22 Nov 2017
Change (% chg)

¥-38 (-2.18%)
Prev Close
¥1,743
Open
¥1,733
Day's High
¥1,740
Day's Low
¥1,705
Volume
404,600
Avg. Vol
393,619
52-wk High
¥1,895
52-wk Low
¥1,540

Chart for

About

Nichi-Iko Pharmaceutical Co., Ltd., a Japan-based company together with its subsidiaries, is principally engaged in the manufacture and sale of generic pharmaceutical products and other medical products. The Company provides its products to medical institutions such as hospitals, medical clinics and dispensing pharmacies. Its... (more)

Overall

Beta: 0.70
Market Cap(Mil.): ¥107,130.20
Shares Outstanding(Mil.): 60.66
Dividend: 15.00
Yield (%): 1.70

Financials

  Industry Sector
P/E (TTM): -- 31.15 16.44
EPS (TTM): -- -- --
ROI: -- 14.99 10.62
ROE: -- 16.33 14.20

BRIEF- Nichi-Iko Pharmaceutical says merger with wholly owned unit

Oct 2Nichi-Iko Pharmaceutical Co Ltd * Says it merged with a wholly owned unit, on Oct. 1 Source text in Japanese:https://goo.gl/Zi3Hxh Further company coverage: (Beijing Headline News)

02 Oct 2017

BRIEF-Nichi-Iko Pharmaceutical and unit says marketing approval for Infliximab BS for I.V. Infusion 100 mg "Nichi-Iko" and "AYUMI"

* Says it received marketing approval for Infliximab BS for I.V. Infusion 100 mg "Nichi-Iko" from the Ministry of Labour, Health, and Welfare on Sept. 27

27 Sep 2017

Earnings vs. Estimates